IDEXX’s 2025 Corporate Responsibility Report highlights new advances in veterinary diagnostics, workforce development and sustainability initiatives. The report details progress toward the company’s long-term goals while showcasing investments designed to expand access to care, strengthen veterinary practices and support future innovation.
Virbac reported first-half 2026 revenue of €768 million, representing 7.4% organic growth at constant exchange rates and scope (CERS), driven by double-digit growth across its Supercharge platforms and balanced gains in both companion and farm animal segments. The company also reaffirmed its full-year financial guidance, citing strong momentum across North America, Europe and international markets despite currency headwinds and localized operational challenges.
CVS Health® is bringing prescription medications for dogs and cats to nearly 9,000 CVS Pharmacy® locations across the U.S., giving pet owners another option for filling common veterinary prescriptions while adding new digital tools to simplify medication management.
PetMeds has officially launched its first large-scale white-label pharmacy program through Rural King, expanding online access to prescription medications, pet food and preventive care products for pet owners, particularly in rural communities.
Synexis has partnered with Penn Veterinary Supply to broaden access to its Dry Hydrogen Peroxide (DHP®) technology, giving veterinary and animal care facilities nationwide greater access to continuous indoor pathogen control solutions.
The Veterinary Angel Network for Entrepreneurs (VANE) has added PawPay to its investment portfolio, supporting a platform designed to eliminate upfront pet insurance reimbursement delays for veterinary practices and pet owners.
Boehringer Ingelheim reported modest first-half 2026 growth in its Animal Health business while advancing new product launches, expanding AI-enabled diagnostics, and supporting responses to emerging livestock disease outbreaks.
Outward Hound has entered a new chapter after H.I.G. Capital assumed majority ownership of the pet products company. The investment is expected to provide additional resources to accelerate innovation across the company’s portfolio of dog and cat brands, strengthen retail partnerships, and support expansion into new product categories as demand in the companion animal market continues to grow.
ImmuCell reported preliminary second-quarter product sales of $7.2 million, an 11.5% increase over the prior-year period, while first-half sales climbed nearly 21% to $17.5 million. The animal health biologics company credited strong domestic demand, improved product availability, and continued growth of its calf health portfolio, although international sales declined during the quarter.
PetMeds has launched its first large-scale white-label online pharmacy program through a new partnership with Rural King, giving the retailer’s customers access to prescription medications, prescription diets, preventatives, and other pet health products through a co-branded digital platform. The initiative is designed to expand access to veterinary pharmacy services, particularly in rural communities where pet healthcare resources may be more limited.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.